PERMUTIT COMPANY, THE – Trademark Portfolio
Entity Type: 03
PERMUTIT COMPANY, THE holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 6 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include RANAREX and "PERMUTIT". The owner is based in NEW YORK, NY.
30 EAST FORTY-SECOND STREET
NEW YORK, NY
Showing of trademarks Trademarks
Trademark Classifications
PERMUTIT COMPANY, THE's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does PERMUTIT COMPANY, THE have?
PERMUTIT COMPANY, THE has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 7 cancelled.
What trademark classes does PERMUTIT COMPANY, THE file in?
PERMUTIT COMPANY, THE files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 31 (Natural Agricultural Products). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are PERMUTIT COMPANY, THE's most well-known trademarks?
PERMUTIT COMPANY, THE's registered trademark portfolio includes well-known marks such as RANAREX and "PERMUTIT". These are among 2 currently registered trademarks in the portfolio.
What is PERMUTIT COMPANY, THE's trademark registration success rate?
PERMUTIT COMPANY, THE has a 22% trademark registration rate, with 2 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.